X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

IOVA

Closed

Iovance Biotherapeutics Inc

1.74
+0.02 (+1.16%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.72
Day's Range: 1.67 - 1.82
Send
When Written:
 
6.27
Iovance Biotherapeutics Inc is a biotechnology company that focuses on developing and commercializing cancer immunotherapy products. The company's lead product candidate, LN-144, is a T-cell therapy being developed for the treatment of metastatic melanoma. The company's other product candidates include LN-145 for cervical and head and neck cancers, and IOV-3001 for solid tumors. Iovance Biotherapeutics was founded in 2007 and is headquartered in San Carlos, California. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol IOVA.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X